ReviewFrontiers in oncology2022

IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma.

Mimma Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.